Physician
Selvaraj, Vijayalakshmi
Selvaraj, Vijayalakshmi was paid $546K by Medicaid between Jan 2018 and Dec 2024, across 37 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 44% of everything it billed.
33Billing provider infoSELVARAJ, VIJAYALAKSHMI
RENFREW, PA 16053
RENFREW, PA 16053
33aNPI1003854563assigned 06/04/2006
33bProvider typePediatrics Physician
28Total paid$546K
24GClaims18,062
24DCodes billed37
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Pennsylvania
Rank by total paid#176 of 1,257
Median peer was paid$45K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 268 | $11K | |
| 2019 | 17 | $916.30 | |
| 2020 | 1,033 | $23K | |
| 2021 | 4,985 | $145K | |
| 2022 | 4,378 | $136K | |
| 2023 | 3,938 | $126K | |
| 2024incomplete | 3,443 | $104K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 44% | 6,100 | 5,156 | $240K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 24% | 1,108 | 1,034 | $128K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.6% | 493 | 491 | $47K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.4% | 339 | 338 | $35K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.4% | 312 | 307 | $30K |
| 87430 | 3.0% | 2,140 | 1,967 | $16K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.2% | 133 | 130 | $12K |
| 99173 | 1.1% | 1,603 | 1,588 | $6K | |
| 87631 | <1% | 33 | 32 | $5K | |
| 99188 | <1% | 244 | 244 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 583 | 528 | $5K |
| 92551 | <1% | 1,527 | 1,510 | $4K |
25 more codes
| 99080 | <1% | 99 | $3K | |
| 90686 | <1% | 642 | $3K | |
| 90672 | <1% | 287 | $1K | |
| 90700 | <1% | 258 | $1K | |
| 90713 | <1% | 137 | $855.00 | |
| 90651 | <1% | 129 | $793.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 15 | $562.95 |
| 90648 | <1% | 97 | $506.00 | |
| 87807 | <1% | 34 | $451.78 | |
| 90670 | <1% | 67 | $343.00 | |
| 96127 | <1% | 559 | $284.30 | |
| 90707 | <1% | 12 | $132.00 | |
| 90734 | <1% | 12 | $132.00 | |
| 90620 | <1% | 12 | $121.00 | |
| 96160 | <1% | 624 | $109.21 | |
| 96161 | <1% | 25 | $84.26 | |
| 82947 | <1% | 12 | $40.78 | |
| 80061 | Lipid panel | <1% | 12 | $34.47 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 37 | $7.69 |
| 90674 | 0% | 67 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 242 | $0.00 |
| 36416 | 0% | 16 | $0.00 | |
| 90619 | 0% | 13 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 13 | $0.00 |
| 90671 | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.